147 related articles for article (PubMed ID: 38376511)
21. Comparative effects of 15 antidepressants on the risk of withdrawal syndrome: A real-world study using the WHO pharmacovigilance database.
Quilichini JB; Revet A; Garcia P; Bouquié R; Hamard J; Yrondi A; Montastruc F
J Affect Disord; 2022 Jan; 297():189-193. PubMed ID: 34699855
[TBL] [Abstract][Full Text] [Related]
22. Reported Adverse Drug Reactions in Children and Adolescents Treated with Antipsychotics.
Minjon L; van den Ban E; de Jong E; Souverein PC; Egberts TCG; Heerdink ER
J Child Adolesc Psychopharmacol; 2019 Mar; 29(2):124-132. PubMed ID: 30676073
[TBL] [Abstract][Full Text] [Related]
23. Safety of clozapine use during pregnancy: Analysis of international pharmacovigilance data.
Beex-Oosterhuis MM; Samb A; Heerdink ER; Souverein PC; Van Gool AR; Meyboom RHB; van Marum RJ
Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):725-735. PubMed ID: 32378285
[TBL] [Abstract][Full Text] [Related]
24. Association between myocarditis and antipsychotics other than clozapine: a systematic literature review and a pharmacovigilance study using VigiBase.
De Las Cuevas C; Sanz EJ; Rohde C; de Leon J
Expert Rev Clin Pharmacol; 2022 Jan; 15(1):65-78. PubMed ID: 35062840
[TBL] [Abstract][Full Text] [Related]
25. Abuse and misuse of second-generation antipsychotics: An analysis using VigiBase, the World Health Organisation pharmacovigilance database.
Roy S; Charreteur R; Peries M; Kheloufi F; Eiden C; Nagot N; Donnadieu-Rigole H; Micallef J; Peyrière H
Br J Clin Pharmacol; 2022 Oct; 88(10):4646-4653. PubMed ID: 35633029
[TBL] [Abstract][Full Text] [Related]
26. Haematologic malignancies associated with clozapine
Chrétien B; Lelong-Boulouard V; Chantepie S; Sassier M; Bertho M; Brazo P; Humbert X; Alexandre J; Fedrizzi S; Dolladille C
Psychol Med; 2021 Jul; 51(9):1459-1466. PubMed ID: 32036793
[TBL] [Abstract][Full Text] [Related]
27. Priapism associated with antipsychotics: role of alpha1 adrenoceptor affinity.
Andersohn F; Schmedt N; Weinmann S; Willich SN; Garbe E
J Clin Psychopharmacol; 2010 Feb; 30(1):68-71. PubMed ID: 20075651
[TBL] [Abstract][Full Text] [Related]
28. Safety profile of antiviral medications: a pharmacovigilance study using the Italian spontaneous-reporting database.
Pugi A; Bonaiuti R; Maggini V; Moschini M; Tuccori M; Leone R; Rossi M; Motola D; Piccinni C; Ferrazin F; Sottosanti L; Mugelli A; Vannacci A; Lapi F
Am J Health Syst Pharm; 2013 Jun; 70(12):1039-46. PubMed ID: 23719881
[TBL] [Abstract][Full Text] [Related]
29. Is There a Potential of Misuse for Quetiapine?: Literature Review and Analysis of the European Medicines Agency/European Medicines Agency Adverse Drug Reactions' Database.
Chiappini S; Schifano F
J Clin Psychopharmacol; 2018 Feb; 38(1):72-79. PubMed ID: 29210868
[TBL] [Abstract][Full Text] [Related]
30. First generation antipsychotic-associated serious adverse events in women: a retrospective analysis of a pharmacovigilance database.
McCall KL; Doughty BJ; Piper BJ; Naik H; Bange S; Leppien EE
Int J Clin Pharm; 2024 Apr; 46(2):515-521. PubMed ID: 38315306
[TBL] [Abstract][Full Text] [Related]
31. Signal of Gastrointestinal Congenital Malformations with Antipsychotics After Minimising Competition Bias: A Disproportionality Analysis Using Data from Vigibase(®).
Montastruc F; Salvo F; Arnaud M; Bégaud B; Pariente A
Drug Saf; 2016 Jul; 39(7):689-96. PubMed ID: 26961536
[TBL] [Abstract][Full Text] [Related]
32. Antipsychotics and seizures: higher risk with atypicals?
Lertxundi U; Hernandez R; Medrano J; Domingo-Echaburu S; García M; Aguirre C
Seizure; 2013 Mar; 22(2):141-3. PubMed ID: 23146619
[TBL] [Abstract][Full Text] [Related]
33. Drug induced stuttering: pharmacovigilance data.
Trenque T; Morel A; Trenque A; Azzouz B
Expert Opin Drug Saf; 2021 Mar; 20(3):373-378. PubMed ID: 33337944
[No Abstract] [Full Text] [Related]
34. Calcitonin gene-related peptide antagonists in pregnancy: a disproportionality analysis in VigiBase
Noseda R; Bedussi F; Gobbi C; Ceschi A; Zecca C
J Headache Pain; 2024 Jan; 25(1):10. PubMed ID: 38243189
[TBL] [Abstract][Full Text] [Related]
35. Association Between Antipsychotics and Osteoporosis Based on Real-World Data.
Yokoyama S; Wakamoto S; Tanaka Y; Nakagawa C; Hosomi K; Takada M
Ann Pharmacother; 2020 Oct; 54(10):988-995. PubMed ID: 32186394
[TBL] [Abstract][Full Text] [Related]
36. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
Yıldız M; Osman E
Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516
[TBL] [Abstract][Full Text] [Related]
37. Differences in VigiBase® reporting of aminoglycoside and capreomycin-suspected ototoxicity during tuberculosis treatment.
Sagwa EL; Souverein PC; Ribeiro I; Leufkens HG; Mantel-Teeuwisse AK
Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):1-8. PubMed ID: 27868278
[TBL] [Abstract][Full Text] [Related]
38. Surveillance of drugs that most frequently induce acute kidney injury: A pharmacovigilance approach.
Hosohata K; Inada A; Oyama S; Furushima D; Yamada H; Iwanaga K
J Clin Pharm Ther; 2019 Feb; 44(1):49-53. PubMed ID: 30014591
[TBL] [Abstract][Full Text] [Related]
39. [No rebound psychosis in a case of switching from clozapine to quetiapine].
Walther S; Baciu D
Psychiatr Prax; 2006 Mar; 33(2):93-4. PubMed ID: 16502388
[TBL] [Abstract][Full Text] [Related]
40. Pleural adverse drugs reactions and protein kinase inhibitors: Identification of suspicious targets by disproportionality analysis from VigiBase.
Mahé J; de Campaigno EP; Chené AL; Montastruc JL; Despas F; Jolliet P
Br J Clin Pharmacol; 2018 Oct; 84(10):2373-2383. PubMed ID: 29943846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
